Registry · KVUE
Does Kenvue Inc. support Israel?
Yes — Kenvue Inc. has documented support for Israel on record. Every claim below links to its source.
Filed under: Household & consumer goods brands · Beauty & cosmetics brands · Pharma & healthcare companies · Companies that support Israel
Background
Kenvue is Johnson & Johnson's consumer-health business, separated in 2023 — it listed on the New York Stock Exchange in May 2023 and completed its split from J&J that August. The distinction matters for this question, because almost everything usually cited about "J&J and Israel" belongs to Johnson & Johnson and stayed there: the 2008 acquisition of Omrix Biopharmaceuticals, the Haifa-based Biosense Webster R&D site, the FutuRx biotech incubator, the 2024 acquisition of Israeli medical-device maker V-Wave, the more than 1,000 J&J employees in Israel, and the $2 million J&J gave to humanitarian relief after 7 October 2023. Those are medical-device and pharmaceutical assets and actions, not consumer health, and none of them transferred to Kenvue. What Kenvue inherited is the consumer-health commercial footprint: an Israeli sales-and-marketing branch of its Greek entity, disclosed in its SEC subsidiary lists, selling Tylenol, Neutrogena, Listerine, Aveeno and Band-Aid into the Israeli market. Searching US, Israeli and international press, we found no post-spinoff Kenvue donation, corporate statement, or political contribution relating to Israel. Kenvue appears in consumer boycott directories chiefly on the strength of its former parent's record and its Israeli distribution — that inheritance is not itself evidence of a Kenvue action, and this page does not treat it as one.
SEC — Kenvue 10-K FY2025, Exhibit 21 (Israel jurisdiction) SEC — Kenvue Form S-4 (separation from Johnson & Johnson) Fox Business (J&J's own account of its Israel operations and $2m donation)
Documented support
| Type | Date | Amount | Recipient | Sources |
|---|---|---|---|---|
| Operations in Israel | 2025-12-28 | — | Israel (consumer-health sales and marketing branch) Kenvue maintains a corporate presence in Israel, disclosed in its own SEC filings. Its Exhibit 21 subsidiary list for fiscal 2025, filed on 20 February 2026, names "Kenvue Hellas Commercial Single Member S.A." with Israel as a jurisdiction; the previous year's list, filed 24 February 2025, named the same entity in its earlier form as the "Israel branch of Johnson & Johnson Hellas Consumer Products Commercial Societe Anonyme," jurisdiction Israel. In practice this is a sales-and-marketing branch of the Greek entity that imports, markets and distributes Kenvue brands — Tylenol, Neutrogena, Listerine, Aveeno, Band-Aid and others — into Israeli pharmacies and supermarkets, rather than a manufacturing site. This is a commercial operation, not a donation. |
Frequently asked questions
Did Kenvue Inc. donate money to Israel or Israeli causes?
We have no records of cash donations, but Kenvue Inc. has documented support of other kinds (Operations in Israel). See the records on this page.
Where does this information come from?
Every record on this page links to its source — news reports, official company statements, tax filings, or government records. 4 distinct sources are cited for Kenvue Inc.. Our methodology page explains the full verification process.
Sources & citations
Record last updated: 2026-07-30